Sentence examples for exogenous glucagon from inspiring English sources

Conversely, exogenous glucagon can increase energy expenditure.

For systemic administration of exogenous glucagon, mice were injected in the peritoneal cavity with human glucagon (1 mg/kg body weight) or saline after 3 h of fasting.

Exendin-4, an exogenous glucagon-like peptide-1 receptor (GLP-1R) agonist, protects the heart from ischemia/reperfusion injury.

Exogenous glucagon-like peptide-2 (or its analogues) may be a potential therapy because of its intestinotropic properties.

The effects of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrients was studied in critically ill patients.

In healthy patients and those with type 2 diabetes, exogenous glucagon-like peptide-1 (GLP-1) decreases blood glucose by suppressing glucagon, stimulating insulin and slowing gastric emptying.

Previous studies have shown beneficial effects of exogenous glucagon-like peptide (GLP -1 on GLP -1mia in critically ill patients, a phenonenon also seen in patients with type 2 diabetes.

The purpose of this study was to determine the effects of exogenous glucagon-like peptide 1 (GLP-1) on the glycaemic response to enteral nutrition in nondiabetic, critically ill patients.

In this issue of Diabetes Care, Sathananthan et al. (1) report differences in the insulinotropic response to exogenous glucagon-like peptide-1 (GLP-1) in healthy volunteers, depending on the presence or absence of certain common polymorphisms of the GLP-1 receptor gene.

Based on these results, antidiabetic agents that preserve, maintain, or improve β-cell function, such as exogenous insulin, glucagon-like peptide 1 analogs, dipeptidyl-peptidase 4 inhibitors, and thiazolidinediones (39), may merit attention for the vulnerable (40) transplant population and early posttransplant period.

With exogenous GLP-1, glucagon secretion from α cells was suppressed in the presence of hyperglycemia and euglycemia but not hypoglycemia.